Elsevier

Life Sciences

Volume 50, Issue 16, 1992, Pages 1149-1155
Life Sciences

Growth Hormone-Releasing Peptide (GHRP) binding to porcine anterior pituitary and hypothalamic membranes

https://doi.org/10.1016/0024-3205(92)90457-ZGet rights and content

Abstract

The synthetic hexapeptide, HisdTrpAlaTrpdPheLysNH2 (GHRP, Growth Hormone-Releasing Peptide), has no structural similarities with any of the GH-releasing peptides known and its action in releasing GH is by a complementary but yet not clearly defined action on the pituitary as well as hypothalamus. Therefore, in vitro studies have been performed to demonstrate and characterize GHRP binding sites on peripheral membranes of both porcine pituitary and hypothalamus. The membrane binding sites were specific, reversible, saturable and time, temperature, pH and concentration dependent under optimum binding assay conditions. The maximum specific binding was observed between pH 5.0 and 6.0. In the presence of Ca2+ and Mg2+ ions, with or without chelating agents there was a significant reduction in the specific binding. Scatchard analysis of these binding sites using increasing doses of unlabeled GHRP revealed a single low affinity site with a 2.1 × 10−5 M and 1.7 × 10−5 M and a maximum number of sites of 10 nmol/mg protein and 5 nmol/mg protein for pituitary and hypothalamus, respectively. It is also observed that (d-Lys3)-GHRP, substance P antagonists and growth hormone-releasing factor analog were potent inhibitors of GHRP binding in both tissues.

References (24)

  • K. Sethumadhavan et al.

    Biochem. Biophys. Res. Commun.

    (1991)
  • O.H. Lowry et al.

    J. Biol. Chem.

    (1951)
  • E.E. Codd et al.

    Neuropharmacol.

    (1989)
  • K.G. Bitar et al.

    Biochem. Biophys. Res. Commun.

    (1991)
  • E.E. Codd et al.

    Neuropharmacol.

    (1988)
  • F.A. Momany et al.

    Endocrinology

    (1981)
  • C.Y. Bowers et al.

    Endocrinology

    (1981)
  • C.Y. Bowers et al.

    Endocrinology

    (1984)
  • A.O. Sartor et al.

    Endocrinology

    (1985)
  • C.Y. Bowers et al.
  • L.A. Kraft et al.

    J. Anim. Sci.

    (1984)
  • M.E. Doscher et al.

    J. Anim. Sci.

    (1984)
  • Cited by (49)

    • Targeting appetite and satiety in diabetes and obesity, via G protein-coupled receptors

      2022, Biochemical Pharmacology
      Citation Excerpt :

      In this setting there has been considerable effort to target GHSR1a to alter food intake and thus modulate body weight. [ d-Lys3]-GHRP-6 is a synthetic peptide identified as a GHSR1a antagonist (prior to GHSR1a cloning) due to its ability to inhibit GHRP-6 dependent growth hormone release [75]. In acute studies [d-Lys3]-GHRP-6 decreases food intake and body weight in mice, however long-term treatment of non-obese diabetic mice (MKR model) with [d-Lys3]-GHRP-6 exacerbates glucose intolerance and increases food intake, acting more like a GHSR1a agonist [76].

    • History to the Discovery of Ghrelin

      2012, Methods in Enzymology
      Citation Excerpt :

      These assay results included specific binding of GHRH, GHRPs, as well as partial and nonpeptide GHSs. GHRP-6 did not bind in the GHRH RRA; however, GHRP-6-specific binding was demonstrated in the hypothalamus and pituitary (Bitar et al., 1991; Codd et al., 1989; Howard et al., 1996, vide infra; Sethumadhavan et al., 1991; Smith et al., 1996, vide infra; Van der Ploeg et al., 1998, vide infra; Veeraragavan et al., 1992). In general, receptor-binding results and GH-releasing results parallel each other.

    • Ghrelin as a novel locally produced relaxing peptide of the iris sphincter and dilator muscles

      2006, Experimental Eye Research
      Citation Excerpt :

      The results of the present study also suggest that the relaxing effects of ghrelin on the iris sphincter muscle are not mediated by GHSR-1a, as they were also observed in response to des-octanoyl-ghrelin. Furthermore, in presence of D-Lys3 GHRP6, an inhibitor of that receptor (Veeraragavan et al., 1992), the relaxing effect of ghrelin was not inhibited, but rather enhanced more than threefold. It should be, however, stressed that even if GHSR-1a does not seem to mediate the relaxing effect of ghrelin, it presumably modulates it, as inhibition of this receptor enhanced the degree of active tension decline.

    • Ghrelin - A hormone with multiple functions

      2004, Frontiers in Neuroendocrinology
    View all citing articles on Scopus
    View full text